249 related articles for article (PubMed ID: 3409330)
1. Cytolytic activity of murine anti-dog lymphoma monoclonal antibodies with canine effector cells and complement.
Rosales C; Jeglum KA; Obrocka M; Steplewski Z
Cell Immunol; 1988 Sep; 115(2):420-8. PubMed ID: 3409330
[TBL] [Abstract][Full Text] [Related]
2. Killing of human tumor cell lines by human monocytes and murine monoclonal antibodies.
Lubeck MD; Kimoto Y; Steplewski Z; Koprowski H
Cell Immunol; 1988 Jan; 111(1):107-17. PubMed ID: 3338092
[TBL] [Abstract][Full Text] [Related]
3. Biological activity in the human system of isotype variants of oligosaccharide-Y-specific murine monoclonal antibodies.
Scholz D; Lubeck M; Loibner H; McDonald-Smith J; Kimoto Y; Koprowski H; Steplewski Z
Cancer Immunol Immunother; 1991; 33(3):153-7. PubMed ID: 2044080
[TBL] [Abstract][Full Text] [Related]
4. In vivo destruction of canine lymphoma mediated by murine monoclonal antibodies.
Steplewski Z; Rosales C; Jeglum KA; McDonald-Smith J
In Vivo; 1990; 4(4):231-4. PubMed ID: 2103365
[TBL] [Abstract][Full Text] [Related]
5. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
Christiaansen JE; Sears DW
Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of antitumor activity in mice for anti-epidermal growth factor receptor monoclonal antibodies with different isotypes.
Masui H; Moroyama T; Mendelsohn J
Cancer Res; 1986 Nov; 46(11):5592-8. PubMed ID: 3756906
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal anti-human tumor antibodies of six isotypes in cytotoxic reactions with human and murine effector cells.
Herlyn D; Herlyn M; Steplewski Z; Koprowski H
Cell Immunol; 1985 Apr; 92(1):105-14. PubMed ID: 4075410
[TBL] [Abstract][Full Text] [Related]
8. Tumor cell lysis and tumor growth inhibition by the isotype variants of MAb BR55-2 directed against Y oligosaccharide.
Steplewski Z; Lubeck MD; Scholz D; Loibner H; McDonald Smith J; Koprowski H
In Vivo; 1991; 5(2):79-83. PubMed ID: 1768791
[TBL] [Abstract][Full Text] [Related]
9. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
Ortaldo JR; Woodhouse C; Morgan AC; Herberman RB; Cheresh DA; Reisfeld R
J Immunol; 1987 May; 138(10):3566-72. PubMed ID: 2437198
[TBL] [Abstract][Full Text] [Related]
10. Functional polymorphisms of Fc receptors in human monocyte-mediated cytotoxicity towards erythrocytes induced by murine isotype switch variants.
Boot JH; Geerts ME; Aarden LA
J Immunol; 1989 Feb; 142(4):1217-23. PubMed ID: 2492577
[TBL] [Abstract][Full Text] [Related]
11. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.
Kipps TJ; Parham P; Punt J; Herzenberg LA
J Exp Med; 1985 Jan; 161(1):1-17. PubMed ID: 3918141
[TBL] [Abstract][Full Text] [Related]
12. Effect of human blood mononuclear cell populations in antibody dependent cellular cytotoxicity (ADCC) using two murine (CO17-1A and Br55-2) and one chimeric (17-1A) monoclonal antibodies against a human colorectal carcinoma cell line (SW948).
Masucci G; Lindemalm C; Frödin JE; Hagström B; Mellstedt H
Hybridoma; 1988 Oct; 7(5):429-40. PubMed ID: 3198133
[TBL] [Abstract][Full Text] [Related]
13. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
[TBL] [Abstract][Full Text] [Related]
14. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Woodhouse CS; Morgan AC
Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
[TBL] [Abstract][Full Text] [Related]
15. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
Fogler WE; Klinger MR; Abraham KG; Gottlinger HG; Riethmuller G; Daddona PE
Cancer Res; 1988 Nov; 48(22):6303-8. PubMed ID: 2460221
[TBL] [Abstract][Full Text] [Related]
16. Canine lymphoma-associated antigens defined by murine monoclonal antibodies.
Steplewski Z; Jeglum KA; Rosales C; Weintraub N
Cancer Immunol Immunother; 1987; 24(3):197-201. PubMed ID: 3594482
[TBL] [Abstract][Full Text] [Related]
17. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H
Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864
[TBL] [Abstract][Full Text] [Related]
18. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
19. Influence of antibody isotype on passive serotherapy of lymphoma.
Denkers EY; Badger CC; Ledbetter JA; Bernstein ID
J Immunol; 1985 Sep; 135(3):2183-6. PubMed ID: 2862210
[TBL] [Abstract][Full Text] [Related]
20. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
Itoh K; Balch CM; Trial J; Platsoucas CD
Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]